Abstract
CD19-targeted chimeric antigen receptor (CAR) T-cells (CAR19s) show remarkable efficacy in the treatment of relapsed/refractory acute lymphocytic leuk......
小提示:本篇文献需要登录阅读全文,点击跳转登录